Skip to main content
Clinical Trials/NCT03330548
NCT03330548CompletedNot Applicable

Pilot Study on the Effects of a Plant-Strong Diet on Cardiovascular Risk Factors

Phoenix VA Health Care System2 sites in 1 country87 target enrollmentStarted: July 9, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
87
Locations
2
Primary Endpoint
Change in Low-density lipoprotein (LDL)

Study Overview

Brief Summary

The purpose of this study is to conduct a preliminary test of the effectiveness of various educational interventions to promote adoption of a whole-food, plant-strong diet and reduce specific cardiovascular risk factors in Veterans, and subsequently perform a preliminary pilot study on whether this dietary approach will change plaque inflammation and endothelial function.

Detailed Description

The purpose of this study is to conduct a preliminary test of the effectiveness of various educational interventions to promote adoption of a whole-food, plant-strong diet and reduce specific cardiovascular risk factors in Veterans, and subsequently perform a preliminary pilot study on whether this dietary approach will change plaque inflammation and endothelial function. The specific aims are to conduct a preliminary examination of:

  1. The feasibility of Veterans to adopt a whole-food, plant-strong diet within five weeks, following a plant-strong protocol, or within 90 days following a Plant Strong Diet (PSD) using Culinary Rx, or by TeleMOVE! (standard of care control). Feasibility factors will evaluate acceptability and practicality by a measure of the recruitment process, attrition rate, reasons for dropping, perceived benefit, and comparison of dietary pattern changes before and after the intervention.

a. Acceptability of a plant-strong diet. 2. (Part 1) The effectiveness of a five-week whole-food, plant-strong diet on participants':

  1. Cardiovascular risk factors: Low-Density Lipoprotein, (LDL-C), High-Density Lipoprotein (HDL), Triglycerides (TG), Total Cholesterol (T Chol), C-Reactive Protein (CRP), basic chemistry panel, blood pressure, weight, waist circumference, and percent body fat.

  2. Dietary pattern, particularly the degree to which meat, fish, dairy, and added oils are decreased or eliminated from the dietary pattern; as well as the degree to which the consumption of fruits and vegetables (particularly whole-food) are increased from baseline intake, and the nutrient composition (percent of calories from protein, fat, carbohydrate, and amount of fiber) of the diet changes.

  3. (Part 3) The effectiveness of completing Culinary Rx as compared to TeleMOVE! for 90 days on participants':

  4. Cardiovascular risk factors: Low-Density Lipoprotein, (LDL-C), High-Density Lipoprotein (HDL), Triglycerides (TG), Total Cholesterol (T Chol), HgbA1c, blood pressure, body mass index, weight, waist to hip ratio, and. medication usage (e.g., blood pressure, hypoglycemic, lipid lowering and anti-depressants).

  5. Dietary pattern, particularly the degree to which meat, fish, dairy, and added oils are decreased or eliminated from the dietary pattern; as well as the degree to which the consumption of fruits and vegetables (particularly whole-food) are increased from baseline intake, and the nutrient composition (percent of calories from protein, fat, carbohydrate, and amount of fiber) of the diet changes.

  6. Long-term lifestyle changes as measured by sustainability of dietary pattern and cardiovascular risk changes that occurred at 90 days and were still present at six months and one year, (excluding change in plaque inflammation and endothelial function).

  7. Establish the ability of Positron Emission Tomography 18F-fluorodeoxyglucose radiopharmaceutical and magnetic resonance imaging (PET FDG-MRI) to assess serial change in plaque inflammation and plaque volume (Part 2) and then perform a pilot test to assess whether a 90-day PSD using Culinary Rx, or TeleMOVE! reduces plaque inflammation using FDG uptake on PET scan and structural changes on MRI (Part 3).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

The assessor for the imaging studies will be blinded to the study arms of the subjects.

Eligibility Criteria

Ages
18 Years to 89 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Inclusion criteria: U.S. Veterans only
  • Age >18 and < 90
  • BMI >25 and < 40
  • Subject has hypertension, diabetes, hyperlipidemia, or overweight/obesity based upon recognized body mass index (BMI) standards) and an interest and desire to make a lifestyle change.Ability to tolerate two FDG-PET-MRI scans.
  • Active telephone contact information (either land line or cell phone)
  • No contraindication to be on a PSD.
  • Access to transportation and a functioning kitchen
  • The ability to prepare meals independently.
  • Access to a computer or tablet with internet access
  • Digital camera or Smartphone
  • For the FDG-PET-MRI subset/portion of the study, there are additional inclusion criteria:
  • Inclusion criteria:
  • Pooled risk cohort score ≥ 7.5%.
  • No contraindication to magnetic resonance imaging (moderate or severe claustrophobia, ferromagnetic materials, inability to lie flat for 30 minutes).

Exclusion Criteria

  • Significant unplanned weight loss within the last six months
  • BMI < 25 or > 40
  • Uncontrolled insulin-dependent diabetes with a current HbA1C of over 9%
  • Contraindication to undertake a PSD
  • Age <18 years old
  • Pregnancy/lactation
  • Taking prescribed weight loss medication(s)
  • Currently following a plant-strong diet, vegan, or medical weight loss program diet
  • Celiac disease diagnosed within the last six months
  • End-stage hepatic disease or renal disease requiring dialysis
  • Active cancer or receiving chemotherapy or radiation therapy
  • Active alcohol or substance abuse problems
  • History of eating disorders
  • Fasting triglyceride level above 350 mg/dL
  • Any psychological issues that prevent compliance
  • Unable to speak the English language
  • Have limited mobility
  • Homeless or in housing with limited kitchen access
  • For the FDG-PET-MRI subset/portion of the study, there are additional exclusion criteria:
  • Inability to tolerate PET scans.
  • Contraindication to magnetic resonance imaging (moderate or severe claustrophobia, ferromagnetic materials, inability to lie flat for 30 minutes)
  • Women of childbearing potential who do not have medical documentation of surgically induced menopause.

Outcomes

Primary Outcomes

Change in Low-density lipoprotein (LDL)

Time Frame: 90 days, 6 months and one year from baseline

Fasting Low-density lipoprotein measured in milligrams per deciliter (mg/dl)

Secondary Outcomes

  • Change in Weight(90 days, 6 months and one year from baseline)
  • Change in carotid plaque(90 days from baseline)
  • Change in Hemoglobin A1C (HgbA1c)(90 days, 6 months and one year from baseline)
  • Change in Total Cholesterol(90 days, 6 months and one year from baseline)
  • Change in Dietary pattern(90 days, 6 months and one year from baseline)
  • Change in aortic pulse wave velocity(90 days from baseline)

Investigators

Sponsor Class
Fed
Responsible Party
Principal Investigator
Principal Investigator

Diane Parrington

Deputy Associate Chief of Staff for Research

Phoenix VA Health Care System

Study Sites (2)

Loading locations...

Similar Trials

Pilot Study on the Effects of a... | Clinical Trial